Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013

 Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal
                           2013 On February 4, 2013

PR Newswire

BOULDER, Colo., Jan. 29, 2013

BOULDER, Colo., Jan. 29, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:
ARRY) will report financial results for the second quarter of fiscal 2013 on
Monday, February 4, 2013, and will hold a conference call on Tuesday, February
5, 2013 at 9:00 a.m. eastern time to discuss these results. Ron Squarer,
Chief Executive Officer and Michael Carruthers, Chief Financial Officer will
lead the call.

Conference Call Information

Date:                  Tuesday, February 5, 2013
Time:                   9:00 a.m. eastern time
Toll-Free:                     (800) 447-0521
Toll:                 (847) 413-3238
Pass Code:                       34113160
Webcast & Conference Call Slides:
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome
A replay of the call will be available as a webcast on www.arraybiopharma.com

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery,
development and commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Array is evolving into a late-stage
development company with significant progress toward generating data to
support our upcoming Phase 3 / pivotal trial decisions. Array-invented MEK162
will be tested in a Phase 3 trial in NRAS melanoma in the next several months
as well as BRAF mutant melanoma later in 2013 (with Novartis). Four other
Array invented drugs are also approaching Phase 3 decisions by the end of
calendar year 2013. These include Array's wholly owned drugs, ARRY-614 and
ARRY-520, and two additional partnered programs, selumetinib (with
AstraZeneca) and danoprevir (with InterMune / Roche). For more information on
Array, please go to www.arraybiopharma.com.

SOURCE Array BioPharma Inc.

Website: http://www.arraybiopharma.com
Contact: Tricia Haugeto, Array BioPharma Inc., +1-303-386-1193,
thaugeto@arraybiopharma.com
 
Press spacebar to pause and continue. Press esc to stop.